The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 115.00
Bid: 114.50
Ask: 121.50
Change: 0.00 (0.00%)
Spread: 7.00 (6.114%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 115.00
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes and Succession

26 Sep 2019 07:00

RNS Number : 7079N
Xaar PLC
26 September 2019
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014

Xaar plc

Board Changes and Succession

The Board of Xaar plc ("Xaar" or the "Company") announces the following succession planning and other Board changes to align with recent business developments.

Following the announcement on 12 September of the proposed further investment in Xaar 3D by Stratasys, Ltd. and the announcement of the results of our strategic review of our Thin Film business today, the Board is announcing changes to its Board to ensure it has the appropriate management and cost structure in place for the next phase of Company development.

Having led to a conclusion the Thin Film strategic review and the next phase of the Stratasys 3D partnership, Doug Edwards, Chief Executive Officer (CEO), has worked with the Board to find a successor and, after five years with the Company, has informed the Board of his wish to leave to explore opportunities back in the USA where his home and family are located.

The Board is pleased to announce that it has appointed John Mills as CEO Designate. John joined Xaar in August 2019 as head of the Printhead Business Unit, and will continue until 31 December 2019 in this role while at the same time preparing for the CEO role. John has extensive experience in the digital print market, having worked at Domino Printing Sciences (1994 to 2001) and most recently was CEO of Inca Digital for five years to October 2018. To reflect his intended position, John joins the Xaar Board of Directors today.

Doug will hand over his CEO role to John on 31 December 2019 but will remain available to the Company until 31 March 2020 to ensure an orderly succession.

Robin Williams, Chairman, has been a Board member for over nine years, until October 2016 as Non-Executive Director, and has recently overseen the CEO succession planning and the Board approach to the strategic review. Now that these priorities are complete or in implementation, and as recommended by the UK Corporate Governance Code, he will provide continuity while the new CEO becomes established over the first part of 2020, but will step down from the Board following the announcement of the preliminary Results for the year at the end of March 2020.

Andrew Herbert, who has been Non-Executive on the Board since June 2016, has agreed to be appointed as Chairman on Robin's retirement from the Board and will accordingly lead the Nomination Committee process for the recruitment of an additional Non-Executive Director to join the Board in due course.

Shomit Kenkare has resigned his role as Chief Financial Officer (CFO) and accordingly will leave the Company on 31 December 2019. A search for a replacement CFO has been initiated by the Nomination Committee and we will update on progress in due course. Shomit is based in the USA, and having supported the Board with its 3D and Thin Film strategic programmes, now wishes to pursue opportunities back in the USA.

Margaret Rice-Jones, Senior Independent Director, has indicated that she will not seek re-election at the 2020 AGM and so will leave the Board at that time, in order to be able to focus on her other Non-Executive responsibilities. The Remuneration Policy will be presented at the 2020 AGM, with Margaret having led the completion of the new policy prior to the AGM.

Andrew Herbert and Chris Morgan's continuing roles as Independent Non-Executives will ensure continuity across the commercial, financial and governance aspects of the Board agenda in the longer term.

No further information is required to be disclosed under Listing Rule 9.6.13R.

 

Enquiries:

Xaar plc

+44 (0)1223 423 663 

Robin Williams, Chairman

Doug Edwards, Chief Executive Officer

 

 

 

 

Tulchan Communications

+44 (0)20 7353 4200

James Macey White

David Ison

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADDGDCXBDBGCU
Date   Source Headline
18th Mar 201612:07 pmRNSDirector/PDMR Shareholding
16th Mar 20167:00 amRNS2015 Full Year Results, 2020 Vision
7th Mar 201610:00 amRNSHolding(s) in Company
1st Mar 201610:13 amRNSTotal Voting Rights
1st Feb 20162:41 pmRNSTotal Voting Rights
22nd Jan 201612:02 pmRNSHolding(s) in Company
18th Jan 20166:16 pmRNSHolding(s) in Company
13th Jan 20167:00 amRNSScheduled Trading Statement
6th Jan 20167:00 amRNSXAAR STRENGTHENS ITS 3D PRINTING BUSINESS
4th Jan 20164:12 pmRNSBlocklisting Interim Review
4th Jan 20163:27 pmRNSTotal Voting Rights
17th Dec 201510:07 amRNSDirector Shareholding
11th Dec 20157:00 amRNSBoard Changes
9th Dec 20154:56 pmRNSHolding(s) in Company
1st Dec 20155:52 pmRNSTotal Voting Rights
25th Nov 20153:46 pmRNSHolding(s) in Company
16th Nov 20159:50 amRNSHolding(s) in Company
9th Nov 20151:53 pmRNSDirector/PDMR Shareholding
4th Nov 20157:00 amRNSInterim Management Statement
2nd Nov 20152:43 pmRNSTotal Voting Rights
7th Oct 20157:00 amRNSNotice of Trading Statement
1st Oct 201510:42 amRNSTotal Voting Rights
1st Sep 20152:43 pmRNSTotal Voting Rights
28th Aug 20153:44 pmRNSDirector Shareholding
27th Aug 20157:01 amRNS2015 Interim Results
26th Aug 20156:01 pmRNSHolding(s) in Company
3rd Aug 201510:25 amRNSTotal Voting Rights
8th Jul 20157:00 amRNSScheduled Trading Statement
7th Jul 20153:28 pmRNSHolding(s) in Company
1st Jul 20151:36 pmRNSBlocklisting Interim Review
1st Jul 20151:33 pmRNSTotal Voting Rights
5th Jun 20157:00 amRNSDirectorate Change
1st Jun 20151:16 pmRNSTotal Voting Rights
1st May 20151:27 pmRNSDirector Shareholding
1st May 201512:37 pmRNSTotal Voting Rights
27th Apr 201510:00 amRNSDirectorate Change
8th Apr 20153:58 pmRNSDirector/PDMR Shareholding
7th Apr 20154:33 pmRNSGrant of Options
7th Apr 20154:31 pmRNSDirector/PDMR Shareholding
31st Mar 20155:23 pmRNSTotal Voting Rights
27th Mar 201510:08 amRNSDirectorate Change
24th Mar 20152:15 pmRNSDirector/PDMR Shareholding
19th Mar 20157:00 amRNS2014 Full Year Results
3rd Mar 20159:51 amRNSTotal Voting Rights
2nd Mar 20157:00 amRNSDirector Appointment
16th Feb 20152:09 pmRNSDirectorate Change
2nd Feb 20155:52 pmRNSTotal Voting Rights
5th Jan 20157:00 amRNSAppointment of CEO
2nd Jan 201510:00 amRNSTotal Voting Rights
2nd Jan 201510:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.